Reduced adhesion of Staphylococcus aureus to ZnO/PVC nanocomposites

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1177-1184

  Geilich, Benjamin M ^a   Webster, Thomas J ^a  

^a Northeastern University   (United States)

Author keywords

Biofilm; Endotracheal tube; Nanomaterials; Nanoparticles; Staphylococcus aureus; Zinc oxide

Indexed keywords

NANOCOMPOSITE; NANOPARTICLE; POLYVINYLCHLORIDE; ZINC OXIDE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIOFILM; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBEDDING; ENDOTRACHEAL TUBE; ENERGY DISPERSIVE X RAY ANALYSIS; IN VITRO STUDY; INTERMETHOD COMPARISON; NONHUMAN; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; SURFACE ENERGY; SURFACE PROPERTY; X RAY ANALYSIS;

BIOFILM; ENDOTRACHEAL TUBE; NANOMATERIALS; NANOPARTICLES; STAPHYLOCOCCUS AUREUS; ZINC OXIDE;

BACTERIAL ADHESION; INTUBATION, INTRATRACHEAL; NANOCOMPOSITES; PARTICLE SIZE; POLYVINYL CHLORIDE; STAPHYLOCOCCUS AUREUS; SURGICAL EQUIPMENT; ZINC OXIDE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84876209180     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S42010     Document Type: Article

References (28)

1. Burke JP. Infection control-a problem for patient safety. N Engl J Med. 2003;348(7):651-656.
2. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious disease. Nat Rev Microbiol. 2004;2(2):95-108.
3. Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol. 2008;74(2):470-476.
4. Otto M. Staphylococcus epidermidis-the 'accidental' pathogen. Nat Rev Microbiol. 2009;7(8):555-567.
5. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating heath care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
6. Fears R, van der Meer JW, ter Meulen V. The changing burden of infectious disease in Europe. Sci Transl Med. 2011;3(103):103cm30.
7. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903.
8. Seil JT, Rubien N, Webster TJ, Tarquinio KM. Comparison of quantification methods illustrates reduced Pseudomonas aeruginosa activity on nanorough polyvinyl chloride. J Biomed Mater Res B Appl Biomater. 2011;98(1):1-7.
9. Fagon JY, Chastre J, Domart Y, Trouillet JL, Gibert C. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis. 1996;23(3): 538-542.
10. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115-2121.
11. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest. 2001;120(2):555-561.
12. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007;13(12):1840-1846.
13. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011.
14. Rosenthal VD, Maki DG, Jamulitrat S, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control. 2010;38(2):95-104. e2.
15. Taylor E, Webster TJ. Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine. 2011;6:1463-1473.
16. Liu H, Webster TJ. Nanomedicine for implants: A review of studies and necessary experimental tools. Biomaterials. 2007;28(2):354-369.
17. Zhang L, Jiang Y, Ding Y, Povey M, York D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanopart Res. 2007;9(3):479-489.
18. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed. 2005;18(6):383-389.
19. Raghupathi KR, Koodali RT, Manna AC. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir. 2011;27(7):4020-4028.
20. Sawai J, Kawada E, Kanou F, et al. Detection of active oxygen generated from ceramic powders having antibacterial activity. J Chem Eng Jpn. 1996;29(4):627-633.
21. Jones N, Ray B, Ranjit KT, Manna AC. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett. 2008;279(1):71-76.
22. Touati D. Iron and oxidative stress in bacteria. Arch Biochem Biophys. 2000;373(1):1-6.
23. Lipovsky A, Tzitrinovich Z, Friedmann H, Applerot G, Gedanken A, Lubart R. EPR study of visible light-induced ROS generation by nanoparticles of ZnO. J Phys Chem C. 2009;113(36):15997-16001.
24. Applerot G, Lipovsky A, Dror R, et al. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS-mediated cell injury. Adv Funct Mater. 2009;19(6):842-852.
25. Zhang L, Webster TJ. Nanotechnology and nanomaterials: promises for improved tissue regeneration. Nano Today. 2009;4(1):66-80.
26. Puckett SD, Taylor E, Raimondo T, Webster TJ. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials. 2010;31(4):706-713.
27. Colon G, Ward BC, Webster TJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A. 2006;78(3):595-604.
28. Shorr AF, Zilberberg MD, Kollef M. Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol. 2009;30(8):759-763.